It has been previously demonstrated that inhibitors targeting mitochondrial oxidative phosphorylation such as biguanides induce death of RCC cells and may become therapeutic options to overcome the disastrous consequences of SOD2-abundance in RCC cells [9]. The gene discussed is SOD2; the disease is renal cell carcinoma.